More evidence on proneurocognitive effects of add-on mirtazapine in schizophreniaSTENBERG, Jan-Henry; TEREVNIKOV, Viatcheslav; JOFFE, Marina et al.Progress in neuro-psychopharmacology & biological psychiatry. 2011, Vol 35, Num 4, pp 1080-1086, issn 0278-5846, 7 p.Article

Population pharmacokinetic analysis of mirtazapineGRASMÄDER, Katja; VERWOHLT, Petra Louise; RAO, Marie Luise et al.European journal of clinical pharmacology. 2004, Vol 60, Num 7, pp 473-480, issn 0031-6970, 8 p.Article

Mirtazapine Decreases the Pain Feeling in Healthy ParticipantsARNOLD, Pierre; VUADENS, Philippe; KUNTZER, Thierry et al.The Clinical journal of pain. 2008, Vol 24, Num 2, pp 116-119, issn 0749-8047, 4 p.Article

Neurologic oral manifestations caused by a new formulation of mirtazapineKLING, A; DAHLQVIST, R; JOHANSSON, S et al.Neurology. 2005, Vol 65, Num 2, pp 333-334, issn 0028-3878, 2 p.Article

Mirtazapine is effective in the prophylactic treatment of chronic tension-type headacheBENDTSEN, Lars; JENSEN, Rigmor.Neurology. 2004, Vol 62, Num 10, pp 1706-1711, issn 0028-3878, 6 p.Article

Placebo-controlled continuation treatment with mirtazapine: Acute pattern of response predicts relapseNIERENBERG, Andrew A; QUITKIN, Frederic M; KREMER, Charlotte et al.Neuropsychopharmacology (New York, NY). 2004, Vol 29, Num 5, pp 1012-1018, issn 0893-133X, 7 p.Article

Influence of mirtazapine on the sexual behavior of male ratsBENELLI, Augusta; FRIGERI, Claudio; BERTOLINI, Alfio et al.Psychopharmacologia. 2004, Vol 171, Num 3, pp 250-258, issn 0033-3158, 9 p.Article

Intravenous mirtazapine is safe and effective in the treatment of depressed inpatientsMÜHLBACHER, M; KONSTANTINIDIS, A; STUPPAECK, C et al.Neuropsychobiology. 2006, Vol 53, Num 2, pp 83-87, issn 0302-282X, 5 p.Article

[N-methyl-¹¹C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humansMARTHI, Katalin; JAKOBSEN, Steen; BENDER, Dirk et al.Psychopharmacologia. 2004, Vol 174, Num 2, pp 260-265, issn 0033-3158, 6 p.Article

Mirtazapine treatment of Generalized Anxiety Disorder : a fixed dose, open label studyGAMBI, Francesco; DE BERARDIS, Domenico; FERRO, Filippo Maria et al.Journal of psychopharmacology (Oxford). 2005, Vol 19, Num 5, pp 483-487, issn 0269-8811, 5 p.Article

Mirtazapine associated with recurrent pancreatitis : a case reportHUSSAIN, Abrar; BURKE, John.Journal of psychopharmacology (Oxford). 2008, Vol 22, Num 3, pp 336-337, issn 0269-8811, 2 p.Article

Therapeutic drug monitoring of mirtazapine, desmethylmirtazapine, 8-hydroxymirtazapine, and mirtazapine-N-oxide by enantioselective HPLC with fluorescence detectionMEINEKE, Ingolf; STEINMETZ, Hannelore; KIRCHHEINER, Julia et al.Therapeutic drug monitoring. 2006, Vol 28, Num 6, pp 760-765, issn 0163-4356, 6 p.Article

Mirtazapine improves alcohol detoxificationLIAPPAS, J; PAPARRIGOPOULOS, T; MALITAS, P et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 1, pp 88-93, issn 0269-8811, 6 p.Article

Mirtazapine in social anxiety disorder: a pilot studyVAN VEEN, J. F; VAN VLIET, I. M; WESTENBERG, H. G. M et al.International clinical psychopharmacology. 2002, Vol 17, Num 6, pp 315-317, issn 0268-1315, 3 p.Article

Adjunct Mirtazapine for Negative Symptoms of SchizophreniaPHAN, Stephanie V; KREYS, Tiffany-Jade M.Pharmacotherapy. 2011, Vol 31, Num 10, pp 1017-1030, issn 0277-0008, 14 p.Article

The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary careROMEO, Renee; PATEL, Anita; KNAPP, Martin et al.International clinical psychopharmacology. 2004, Vol 19, Num 3, pp 125-134, issn 0268-1315, 10 p.Article

The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in EnglandBISWAS, Pipasha N; WILTON, Lynda V; SHAKIR, Saad A. W et al.Journal of psychopharmacology (Oxford). 2003, Vol 17, Num 1, pp 121-126, issn 0269-8811, 6 p.Article

Association of the adrenergic alpha 2a receptor -1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorderLEE, Hwa-Young; KANG, Rhee-Hun; PAIK, Jong-Woo et al.Brain research. 2009, Vol 1262, pp 1-6, issn 0006-8993, 6 p.Article

An Open-Label Study of Mirtazapine as Treatment for Combat-Related PTSDALDERMAN, Christopher P; CONDON, John T; GILBERT, Andrew L et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 7-8, pp 1220-1226, issn 1060-0280, 7 p.Article

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cellsCHAPAGAIN, Moti L; SUMIBCAY, Laarni; GURJAV, Ulziijargal et al.Journal of neurovirology. 2008, Vol 14, Num 5, pp 448-454, issn 1355-0284, 7 p.Article

Mirtazapine abolishes hyperthermia in an animal model of serotonin syndromeSHIODA, Katsutoshi; NISIJIMA, Koichi; YOSHINO, Tatsuki et al.Neuroscience letters. 2010, Vol 482, Num 3, pp 216-219, issn 0304-3940, 4 p.Article

Mirtazapine enantiomers in blood and cerebrospinal fluidBAUMANN, Pierre; JONZIER -PEREY, Michele; PAUS, Erik et al.Neuropsychobiology. 2006, Vol 54, Num 3, pp 179-181, issn 0302-282X, 3 p.Article

Mirtazapine-induced serotonin syndromeUBOGU, Eroboghene E; KATIRJI, Bashar.Clinical neuropharmacology. 2003, Vol 26, Num 2, pp 54-57, issn 0362-5664, 4 p.Article

New onset multimodal hallucinations associated with mirtazapine: a case reportPADALA, Kalpana P; PADALA, Prasad R; MALLOY, Timothy et al.International psychogeriatrics. 2010, Vol 22, Num 5, pp 837-839, issn 1041-6102, 3 p.Article

A case of mirtazapine-induced spontaneous orgasms in a female patientSHALEV, H; BEN-ZION, I; SHIBER, A et al.Journal of psychopharmacology (Oxford). 2009, Vol 23, Num 1, pp 109-110, issn 0269-8811, 2 p.Article